InfiCure Bio AB: € 50k

InfiCure Bio is a Swedish Life Science company that was founded in 2015 with the primary objective of developing and commercializing a proprietary model for preclinical efficacy testing of anti-inflammatory and anti-fibrotic drugs. InfiCure Bio AB was granted € 50k from the SME Instrument HORIZON 2020, phase 1. GAEU’s team at Horizon 2020 Centre of Excellence wrote the proposal.

MORE REFERENCES

FOLLOW US